Population pharmacokinetics and dosing optimisation of ceftazidime in infants.

about

Population pharmacokinetics and dosing optimisation of ceftazidime in infants.

Item

http://www.wikidata.org/entity/Q47645055

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Population pharmacokinetics and dosing optimisation of ceftazidime in infants.

@en

Population pharmacokinetics and dosing optimisation of ceftazidime in infants.

@nl

type

Item

label

Population pharmacokinetics and dosing optimisation of ceftazidime in infants.

@en

Population pharmacokinetics and dosing optimisation of ceftazidime in infants.

@nl

prefLabel

Population pharmacokinetics and dosing optimisation of ceftazidime in infants.

@en

Population pharmacokinetics and dosing optimisation of ceftazidime in infants.

@nl

P1476

Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Infants

@en

P2093

Evelyne Jacqz-Aigrain

http://www.w3.org/2001/XMLSchema#string

Gu-Ying Zhang

http://www.w3.org/2001/XMLSchema#string

Lei Dong

http://www.w3.org/2001/XMLSchema#string

Li-Yuan Tian

http://www.w3.org/2001/XMLSchema#string

Totsapol Jirasomprasert

http://www.w3.org/2001/XMLSchema#string

Xing-Kai Chen

http://www.w3.org/2001/XMLSchema#string

Ya-Kun Wang

http://www.w3.org/2001/XMLSchema#string

Zhong-Ren Shi

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.

Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.

Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.

Pharmacokinetics of ceftazidime in normal and uremic subjects.

Cefepime and Ceftazidime Safety in Hospitalized Infants.

Pharmacokinetics and pharmacodynamics of antibacterial agents.

Mechanism-based concepts of size and maturity in pharmacokinetics.

Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.

P31

scholarly article

P356

10.1128/AAC.02486-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wei Zhao

P577

2018-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29378703

http://www.w3.org/2001/XMLSchema#string

P932

5913974

http://www.w3.org/2001/XMLSchema#string